Parkin has been suspected to be a tumor suppressor: its expression increases oxidative metabolism, limits the Warburg Effect and regulates levels of cyclin D1, cyclin E and cyclin-dependent kinase 4 (CDK4) in cancers [267]. This evidence concerns the gene CDK4 and neoplasm.